Skip to main content
SpringerLink
Log in
Book cover

Imaging Gliomas After Treatment pp 59–63Cite as

PET Imaging

  • Chapter
  • First Online:

  • 439 Accesses

Abstract

The diagnostic capabilities are explained both by methods using gamma emitters radiopharmaceuticals (SPET-TC) and by methods using positronic radiopharmaceuticals (PET-CT and PET-NMR). However, the role of standard in the diagnosis of gliomas remains a specific prerogative of radiological diagnostic techniques (CT and MRI).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Abdel-Dayem HM, et al. Role of Tl-201 chloride and Tc-99m-sestamibi in tumor imaging. Nucl Med Annual. 1994:181–234.

    Google Scholar 

  2. Chen W. Clinical applications of PET in brain tumors. J Nucl Med. 2007;48:1468–81.

    Article  Google Scholar 

  3. Singhal T, et al. 11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhanced MRI. Nucl Med. 2012;53:1709–15.

    Article  Google Scholar 

  4. Unet V, et al. Peformance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and metaanalysis. J Nucl Med. 2012;53:207–14.

    Article  Google Scholar 

  5. Walter F, et al. Impact of 3,4-Dihydroxy-6-18F-Fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring Physician's perspective. J Nucl Med. 2012;53:393–8.

    Article  CAS  Google Scholar 

  6. Cher LM, et al. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J Nucl Med. 2006;47:410–8.

    CAS  PubMed  Google Scholar 

  7. Langleben DD, Segall GM. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med. 2001;41:1861–7.

    Google Scholar 

  8. Paganelli G, et al. Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur J Nucl Med. 1999;26(4):348–35.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, “Dimiccoli” Hospital—ASL BT, Barletta, Italy

    Pasquale Di Fazio

Authors
  1. Pasquale Di Fazio
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology/ Neuroradiology, Ospedale ‘L.Bonomo’, Andria, Italy

    Tommaso Scarabino

  2. Department of Radiology/ Neuroradiology, Ospedale ‘L.Bonomo’, Andria, Italy

    Saverio Pollice

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Di Fazio, P. (2020). PET Imaging. In: Scarabino, T., Pollice, S. (eds) Imaging Gliomas After Treatment. Springer, Cham. https://doi.org/10.1007/978-3-030-31210-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-31210-7_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-31209-1

  • Online ISBN: 978-3-030-31210-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation